Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Puppy successfully treated for vitamin D poisoning
Miniature dachshund Margot arrived at the hospital with depression, lethargy and nausea.

Miniature dachshund Margot is recovering after devouring human psoriasis medication.

A puppy has been treated successfully for vitamin D poisoning after eating a human medicine containing a synthetic form of the supplement. 

Miniature dachshund Margot was presented to Davies Veterinary Specialists after gobbling up a tube of Dovonex ointment - a topical cream used to treat psoriasis in humans that contains
calcipotriol, a synthetic derivative of vitamin D.

“We calculated that four-month-old Margot had ingested between 500-1000µg (161µg/kg – 323µg/kg) of calcipotriol,” explained Katherine Clarke, an internal medicine resident at Davies. “Toxicity studies in dogs suggest that 1.8 to 3.6µg /kg /day of calcipotriol can cause disturbances in calcium homeostasis, so it wasn’t surprising that Margot developed evidence of toxicity.” 

Margot arrived at the veterinary hospital with depression, lethargy and nausea. She was also severely hypercalcaemic and mildly azotaemic.

The team initially managed her vitamin D poisoning with prednisolone, furosemide and intravenous fluid therapy. While she did show some clinical improvement, the hypercalcaemia persisted, prompting the addition of pamidronate to her treatment. 

The combination of the treatments resulted in normocalcaemia and resolution of the azotaemia. The furosemide was then stopped, and the intravenous fluid therapy was gradually reduced over a few days; her calcium remained normal. 

Margot was discharged on tapering doses of prednisolone and blood tests were performed before each dose reduction to ensure she remained normocalcaemic. She is now said to be be clinically very well having been off all treatment for a few months, and there are no signs that the vitamin D poisoning has led to any permanent damage. 

“Vitamin D toxicity is relatively rare, although the growing trend in vitamin D supplementation in the human population means that dogs are more likely to have access to this vitamin,” said Katherine. 

“Ingestion of psoriasis cream, either by licking it from the skin of the owner or direct ingestion by chewing the tube, is another well-recognised mechanism of vitamin D toxicity in dogs,” she continued. “The addition of vitamin D (cholecalciferol) to rodenticides is also increasing, ingestion of which would cause the undesirable combination of vitamin D toxicosis and a coagulopathy”.

“The prognosis for vitamin D toxicity is variable with some cases experiencing an acute kidney injury or severe gastrointestinal bleeding due to calcification of the soft tissues. However, with prompt, aggressive treatment the prognosis can be reasonable.”

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.